Benign neoplasm of breast

CD2_BENIGN_BREAST

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D24& Hospital discharge: ICD-9 — 217 Hospital discharge: ICD-8 — 21799 Cause of death: ICD-10 — D24& Cause of death: ICD-9 — 217 Cause of death: ICD-8 — 21799 2 out of 7 registries used, show all original rules.	4945
4. Check minimum number of events None	4945
5. Include endpoints None	4945
6. Filter based on genotype QC (FinnGen only)	4945

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum mammae

NAME	CD2_BENIGN_BREAST
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D24
HD_ICD_9	217
HD_ICD_8	21799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D24
COD_ICD_9	217
COD_ICD_8	21799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm of breast

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36691	36691	-
Only index persons	33454	33454	-
Unadjusted period prevalence (%)
Whole population	1.05	1.05	-
Only index persons	1.23	1.23	-
Median age at first event (years)
Whole population	-	43.94	-
Only index persons	-	42.89	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4945	4945	-
Unadjusted period prevalence (%)	1.69	1.69	-
Median age at first event (years)	42.55	42.55	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4473: Matched controls
44730

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D24

ICD-10 Finland

Benign neoplasm of breast

3842.7

323.0

2984

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

+∞

323.0

621

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

36.0

323.0

1360

536

9702

FHL

Breast exploration and possible tumor removal

21.4

323.0

530

279

N63

ICD-10 Finland

Unspecified lump in breast

6.8

323.0

1095

2030

21799

ICD-8 Finland

Benign neoplasm of breast

+∞

323.0

927

HAB99

NOMESCO Finland

Other partial excision of mammary gland

8.2

207.9

495

672

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.6

150.2

761

2385

HAA10

NOMESCO Finland

Biopsy of mammary gland

13.8

116.5

206

156

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.0

115.9

338

598

N60.2

ICD-10 Finland

Fibroadenosis of breast

14.8

111.5

191

134

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.2

93.0

537

1814

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.5

87.3

327

763

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

5.7

85.0

259

481

HA1AA

NOMESCO Finland

X-ray mammography

2.6

83.7

683

2873

9703

FHL

Breast resection

9.0

82.2

180

208

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

3.7

69.0

328

947

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

55.5

1103

6742

N64.5

ICD-10 Finland

Other signs and symptoms in breast

4.2

54.4

219

545

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

7.5

53.7

130

177

N64.9

ICD-10 Finland

Disorder of breast, unspecified

5.4

41.4

128

242

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.3

40.4

389

1751

X19

ICPC

Breast lump/mass female

3.9

38.0

163

430

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.4

35.9

134

311

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.7

35.4

161

447

115

Kela drug reimbursment

Breast cancer

1.9

35.2

575

3225

HAB20

NOMESCO Finland

Excision of lactiferous duct

11.0

32.9

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

16.4

32.4

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

3.7

32.3

148

414

C50.99

ICD-10 Finland

Breast, unspecified

2.7

31.8

222

836

ZXA05

NOMESCO Finland

Left side

1.6

30.8

1101

7739

N60.8

ICD-10 Finland

Other benign mammary dysplasias

9.5

28.6

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.9

27.8

171

595

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

9.3

26.4

ZXA00

NOMESCO Finland

Right side

1.5

26.1

1150

8421

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.9

25.3

386

2099

HAC20

NOMESCO Finland

Total mastectomy

2.1

25.2

292

1425

HA5CB

NOMESCO Finland

Galactography

11.3

24.6

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

24.3

1090

7990

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

2.8

23.9

163

606

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

3.6

23.0

104

290

PJA12

NOMESCO Finland

Sentinel node biopsy

1.7

22.8

471

2837

N60.0

ICD-10 Finland

Solitary cyst of breast

5.5

22.7

126

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.4

22.2

108

320

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.7

22.1

160

617

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.4

21.4

L02BA01

ATC

tamoxifen; oral

2.0

20.5

262

1330

HAE99

NOMESCO Finland

Other reconstruction of breast

4.3

20.3

175

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.9

19.3

276

1466

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

3.1

19.1

109

361

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

3.2

18.8

313

N64.8

ICD-10 Finland

Other specified disorders of breast

6.0

17.9

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.0

17.9

240

1244

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.0

17.3

217

1097

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

3.8

17.2

195

C50

ICD-10 Finland

Malignant neoplasm of breast

2.3

16.6

153

673

HA1AE

SPAT

2.8

16.3

106

387

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

16.1

1339

10817

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

15.9

1501

12354

A02BC05

ATC

esomeprazole; systemic

1.3

15.3

1679

14093

L02BG04

ATC

letrozole; oral

1.7

15.3

364

2278

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

3.8

15.3

170

N64.4

ICD-10 Finland

Mastodynia

2.2

15.2

160

751

N61

ICD-10 Finland

Inflammatory disorders of breast

2.4

14.8

128

549

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

14.8

914

7024

TQW20

NOMESCO Finland

Tatoe

3.1

14.2

262

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

14.1

224

1238

J01DB01

ATC

cefalexin; oral

1.3

14.1

3435

31934

X21

ICPC

Breast sympt/compl female other

2.4

14.1

123

531

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

2.6

14.0

101

393

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

13.9

291

1753

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.6

13.9

102

401

R4110

NOMESCO Finland

Physiotherapy

1.3

13.8

1020

8053

61000

ICD-8 Finland

Chronic cystic disease of breast, Fibroadenomatosis mammae

3.7

13.7

161

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

4.6

13.5

101

WX402

NOMESCO Finland

General anaesthesia

1.4

13.2

622

4541

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

4.6

13.0

Z00.0

ICD-10 Finland

General medical examination

1.4

12.9

694

5191

N02BE01

ATC

paracetamol; systemic, rectal

1.3

12.6

3720

35145

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

2.8

12.1

273

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.8

12.1

210

1196

61099

ICD-8 Finland

Chronic cystic disease of breast, Unspecified

4.7

12.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

12.0

1521

12901

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.3

12.0

106

462

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

4.3

11.9

101

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

11.9

366

2446

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.4

11.8

401

R51.80

ICD-10 Finland

Headache

1.4

11.8

607

4503

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.6

11.7

308

1978

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

11.7

971

7780

N60.4

ICD-10 Finland

Mammary duct ectasia

7.7

11.6

THA00

NOMESCO Finland

Needle biopsy of mamilla

8.1

11.5

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

15.0

11.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

2.9

11.1

237

WX110

NOMESCO Finland

Local anesthesy

1.2

11.0

2778

25423

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.9

1027

8362

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

10.9

529

3880

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

10.6

1396

11855

X18

ICPC

Breast pain female

2.5

10.6

342

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

11.2

10.5

Z31.5

ICD-10 Finland

Genetic counselling

1.7

10.5

211

1259

J02AC01

ATC

fluconazole; systemic

1.2

10.5

1981

17518

N62

ICD-10 Finland

Hypertrophy of breast

1.7

10.5

197

1153

D05.0

ICD-10 Finland

Lobular carcinoma in situ

6.2

10.4

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.4

232

1430

A04AA02

ATC

granisetron; systemic, transdermal

1.6

10.1

233

1444

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

10.1

1069

8822

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.0

9.9

130

673

HAC25

NOMESCO Finland

Radical mastectomy

3.9

9.8

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.3

9.6

140

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.3

9.5

136

J01FA10

ATC

azithromycin; systemic

1.2

9.2

2456

22380

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

9.0

159

917

J01DA01

ATC

[U] cefalexin; systemic

1.2

9.0

2549

23353

HA1RA

SPAT

1.9

8.9

128

685

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

3.8

8.8

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

4.1

8.7

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

8.7

120

634

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.3

8.6

315

H02AB02

ATC

dexamethasone; systemic

1.4

8.5

402

2931

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1.6

8.5

224

1442

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

4.1

8.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

1.9

8.3

123

670

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.4

8.2

423

3132

A03FA02

ATC

cisapride; oral, rectal

1.5

8.2

299

2077

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

8.1

201

1276

9719

FHL

Other measure in this category

4.8

8.0

D01

ICPC

Abdominal pain/cramps general

1.4

8.0

410

3032

5702

FHL

Local lymph node removal (eg armpit, groin)

4.1

7.9

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

2.5

7.9

232

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

3.0

7.8

146

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

3.6

7.8

N60.3

ICD-10 Finland

Fibrosclerosis of breast

9.4

7.8

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

3.1

7.8

130

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

7.8

557

4348

ZZF00

NOMESCO Finland

Graft of adipose tissue

2.6

7.7

194

HAB10

NOMESCO Finland

Microductectomy of mammary gland

45.0

7.7

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.0

7.7

142

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

2.9

7.7

151

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

7.7

204

1317

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

7.6

633

5043

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.0

7.6

446

A02BC02

ATC

pantoprazole; systemic

1.2

7.5

2623

24297

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

7.5

457

3483

N03AX16

ATC

pregabalin; oral

1.2

7.5

885

7373

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

3.7

7.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

7.4

908

7591

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

7.4

798

6574

J01MA02

ATC

ciprofloxacin; systemic

1.2

7.4

1326

11549

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.3

1688

15046

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

2.3

7.3

270

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

3.1

7.3

125

X79

ICPC

Benign neoplasm breast female

6.8

7.3

SPAT1336

SPAT

Request for examination

1.7

7.2

139

824

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

3.7

7.1

A02BC01

ATC

omeprazole; systemic

1.2

7.1

1024

8711

UJF32

NOMESCO Finland

Coloscopy

1.2

7.1

930

7831

C07AA05

ATC

propranolol; systemic

1.3

7.1

772

6365

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

7.1

566

4488

EB1SA

SPAT

1.7

7.0

132

777

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

2.8

6.8

149

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.8

1403

12362

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

6.7

2523

23399

L02

ICPC

Back symptom/complaint

1.4

6.7

337

2487

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

5.2

6.6

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

6.5

175

1137

ZXA10

NOMESCO Finland

Bilateral

1.3

6.5

690

5664

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

2.5

6.5

182

S18

ICPC

Laceration/cut

1.2

6.5

1484

13181

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

6.4

198

1327

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

2.9

6.4

120

R05

ICPC

Cough

1.2

6.4

854

7201

N05CF01

ATC

zopiclone; oral

1.2

6.4

1203

10501

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

6.3

191

1274

S04

ICPC

Lump/swelling localized

1.4

6.3

333

2475

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

1.7

6.3

120

711

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

6.3

465

3647

R42

ICD-10 Finland

Dizziness and giddiness

1.2

6.3

801

6719

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

2.7

6.2

140

8113

FHL

Fractional scraping

1.4

6.2

326

2426

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

2.6

6.2

157

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

2.6

6.2

157

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

6.1

378

2884

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

6.1

421

3267

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

1.9

6.1

429

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

6.1

928

7929

N02AX02

ATC

tramadol; systemic, rectal

1.2

6.0

1490

13304

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

4.4

6.0

9733

FHL

Excision of skin change in operating room or anesthesia

2.3

6.0

237

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.0

1673

15085

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

3.0

6.0

103

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768793) Breast Pathology biopsy report

640

1535

4.64

247.21

1.4

1.3

—

(3002256) Pathology report gross observation

1004

5693

1.96

71.05

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

2524

18957

1.68

67.17

2.2

2.1

—

(4035726)

644

4031

1.69

30.52

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1744

13780

1.41

27.28

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4242

40030

1.42

16.01

13.6

12.3

ml/min/173m2

81.5

81.0

0.85

3488

32845

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2254

19540

1.28

15.93

5.1

5.2

mmol/l

1.2

3.08

2015

17568

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

216

1204

1.83

15.20

1.3

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

2345

20587

1.26

14.37

6.0

5.9

28.9

28.7

0.31

2181

19047

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1275

10372

1.31

14.35

2.2

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3576

33058

1.30

14.20

7.9

7.2

u/l

75.8

77.1

1.22

3352

30946

(3018010) Neutrophils/100 leukocytes in Blood

2312

20326

1.26

13.77

5.8

5.7

56.7

56.9

0.19

2153

18867

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2448

21667

1.26

13.74

5.7

5.9

mmol/l

1.2

2.02

2073

18142

(42870588) Differential panel, method unspecified - Blood

1686

14291

1.27

13.63

5.7

5.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2490

22119

1.25

13.40

6.1

5.7

umol/l

9.7

10.2

3.15

2351

20826

(3019069) Monocytes/100 leukocytes in Blood

2276

20044

1.25

13.10

6.2

6.1

8.3

0.12

2122

18643

(3006504) Eosinophils/100 leukocytes in Blood

2264

19928

1.25

13.09

5.9

2.7

2.8

1.45

2101

18421

(3007164) IgA [Mass/volume] in Serum or Plasma

1096

8884

1.30

12.39

1.5

1.4

g/l

2.1

2.3

1.24

588

5213

(3022096) Basophils/100 leukocytes in Blood

2189

19306

1.24

12.07

6.0

5.9

0.7

0.37

2031

17858

(3013650) Neutrophils [#/volume] in Blood by Automated count

2752

24944

1.23

11.50

9.2

8.9

e9/l

3.9

4.0

1.29

2384

21780

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4444

42734

1.39

10.97

14.3

13.3

mg/l

19.8

21.0

1.64

3502

33661

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

794

6253

1.32

10.95

2.7

e6/l

4.1

4.5

0.33

386

3160

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2290

20431

1.23

10.90

3.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2246

20056

1.22

10.42

2.3

nmol/l

81.2

79.1

2.66

1992

18065

(3019225) pH of Specimen

583

4424

1.36

10.29

3.5

4.1

—

(3013512) EKG study

1419

12101

1.24

10.20

3.7

3.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3486

32605

1.23

9.97

4.4

4.2

mm/h

11.9

12.7

3.06

3217

30139

(3037467) Urinalysis macro (dipstick) panel - Urine

3264

30337

1.22

9.84

5.0

4.6

—

(3033658) Prothrombin time (PT) actual/Normal

1243

10490

1.25

9.74

3.4

3.5

94.5

94.9

0.20

1211

10176

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

676

5307

1.32

9.45

4.3

4.4

33.8

33.6

0.15

451

3522

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

197

1230

1.63

9.33

4.1

3.6

u/ml

44.9

33.7

0.29

190

1195

(40758558) Short blood count panel - Blood

1299

11087

1.23

9.07

6.8

6.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4281

41132

1.30

9.00

5.7

5.4

mu/l

1.8

2.1

1.78

3960

37951

(40768797) Stomach Pathology biopsy report

782

6320

1.28

8.74

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1685

14840

1.21

8.47

3.6

e6/l

118.0

111.6

0.08

1085

9970

(3019198) Lymphocytes [#/volume] in Blood

2404

21931

1.19

8.01

5.7

e9/l

1.9

0.87

2101

19276

(3013115) Eosinophils [#/volume] in Blood

2424

22148

1.19

7.88

5.9

e9/l

0.2

0.48

2113

19397

(3009542) Hematocrit [Volume Fraction] of Blood

4037

38648

1.24

7.83

16.3

14.5

38.9

0.04

3058

27699

(3015377) Calcium [Moles/volume] in Serum or Plasma

1745

15537

1.19

7.56

3.9

3.2

mmol/l

2.4

1.12

1499

13451

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1234

10660

1.21

7.40

1.3

u/ml

1.2

1.6

0.70

269

2859

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1973

17786

1.18

7.33

2.0

pmol/l

100.5

98.8

0.72

886

8465

(3006315) Basophils [#/volume] in Blood

2339

21404

1.18

7.21

5.8

5.7

e9/l

0.0

0.20

1999

18413

(3001604) Monocytes [#/volume] in Blood

2330

21316

1.18

7.20

5.7

e9/l

0.6

0.04

1994

18345

(3023103) Potassium [Moles/volume] in Serum or Plasma

4494

43665

1.32

7.18

15.8

15.0

mmol/l

3.9

1.62

4368

42459

(3018418) pH of Serum or Plasma

1493

13161

1.19

7.15

3.8

7.4

0.13

235

2504

(3002582) Erythrocytes [#/volume] in Urine

1384

12144

1.19

6.94

3.0

3.1

e6/l

43.0

69.5

0.97

991

9070

(3019550) Sodium [Moles/volume] in Serum or Plasma

4481

43559

1.31

6.84

15.6

14.9

mmol/l

139.6

139.7

0.30

4367

42453

(3031040) Bacteria [#/volume] in Urine by Automated count

3157

29678

1.18

6.77

5.2

4.8

e6/l

1257.1

2291.2

0.80

352

(3032080) INR in Blood by Coagulation assay

1748

15678

1.18

6.75

7.5

7.7

inr

1.2

0.47

501

4585

(36304419) Bacteria [Presence] in Urine

1271

11095

1.20

6.72

2.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1140

9860

1.20

6.65

1.7

mg/l

1.0

1.1

0.27

849

7471

(40761535) Cells panel - Urine sediment

253

3483

0.71

6.42

3.5

3.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2179

19948

1.17

6.40

2.9

2.8

ug/l

90.9

95.3

0.47

2005

18449

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

427

3323

1.31

6.33

3.1

pmol/l

4.5

4.4

0.13

376

2936

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

324

1.99

6.25

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

818

6889

1.22

6.24

2.6

e6/l

1.3

1.9

0.71

414

3771

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4612

45091

1.34

6.11

11.3

10.3

u/l

23.1

23.4

0.98

4454

43458

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1522

13614

1.17

5.89

3.0

3.1

u/l

28.8

31.6

2.25

1430

12862

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

477

3808

1.28

5.83

2.0

2.1

g/l

0.2

0.01

444

3570

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1266

11200

1.18

5.57

2.6

2.8

ng/l

1112.1

1167.9

0.17

1054

9531

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

502

4069

1.26

5.42

2.2

2.3

u/l

33.2

37.6

0.91

433

3418

(36660697) Celiac disease serology panel - Serum

473

3812

1.27

5.36

1.1

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3773

36238

1.17

5.31

4.8

4.5

pmol/l

14.8

0.27

3441

33125

(3030467) Casts [#/volume] in Urine by Automated count

1272

11296

1.17

5.30

3.0

e6/l

0.3

0.4

1.74

890

8364

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

122

784

1.57

5.29

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

682

5764

1.21

4.98

2.0

2.1

ug/g

119.4

118.3

0.02

505

4434

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2928

27666

1.14

4.96

3.3

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2912

27507

1.14

4.95

3.0

2.9

u/l

40.0

41.0

0.24

2683

25478

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.67

4.92

1.5

2.7

u/field

1.0

0.9

0.16

(3023368) Bacteria identified in Blood by Culture

1129

9991

1.17

4.86

3.8

4.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

457

3718

1.25

4.79

3.1

3.7

u/ml

33.4

57.9

4.18

444

3580

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

441

3592

1.25

4.58

3.1

ng/l

76.1

80.9

0.61

377

3012

(40761511) CBC panel - Blood by Automated count

4530

44366

1.25

4.53

13.3

12.6

—

(3017732) Neutrophils [#/volume] in Blood

383

3088

1.26

4.36

2.9

2.7

e9/l

3.9

4.0

0.88

289

2401

(4034850)

1413

0.64

4.25

7.5

9.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

183

1336

1.38

4.24

1.7

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

555

1.60

4.21

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

299

2351

1.29

4.18

1.6

—

(3007461) Platelets [#/volume] in Blood

4769

47065

1.37

4.14

21.9

20.0

e9/l

261.0

263.4

1.88

4645

45902

(3000963) Hemoglobin [Mass/volume] in Blood

4772

47101

1.38

4.12

22.0

20.1

g/l

131.3

131.7

1.46

4712

46468

(3042936) Bacteria identified in Isolate by Culture

646

5538

1.19

4.04

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1104

9876

1.15

4.04

1.5

nmol/l

22.1

21.5

0.71

923

8359

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

545

4604

1.21

4.00

4.0

3.7

ug/l

9.3

29.2

1.48

429

3609

(3026361) Erythrocytes [#/volume] in Blood

4769

47090

1.36

3.88

21.9

20.0

e12/l

4.4

2.14

4634

45798

(3024731) MCV [Entitic volume]

4768

47084

1.35

3.83

21.8

20.0

91.0

90.9

0.23

4707

46443

(3035941) MCH [Entitic mass]

4768

47085

1.35

3.82

21.8

19.9

30.1

0.39

4707

46442

(3015736) pH of Urine

1818

16861

1.12

3.75

3.7

—

5.8

—

(3010813) Leukocytes [#/volume] in Blood

4768

47096

1.35

3.71

22.0

20.0

e9/l

6.5

6.6

2.45

4633

45793

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

107

733

1.47

3.57

3.9

3.7

u/ml

60.8

44.5

0.46

107

725

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1648

15236

1.12

3.55

3.4

3.5

ng/l

26.9

73.2

0.79

1048

9617

(3014765) Yersinia sp identified in Stool by Organism specific culture

182

1371

1.34

3.52

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

180

1354

1.34

3.51

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

739

6488

1.16

3.47

1.6

—

(3024928) Oxygen saturation in Venous blood

104

717

1.46

3.38

2.3

2.7

—

(4094501)

139

1012

1.38

3.35

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

4564

1.19

3.32

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

181

1377

1.33

3.29

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

176

1334

1.33

3.28

2.6

2.2

g/l

0.6

0.7

0.03

148

1133

(3026782) Osmolality of Urine

881

7873

1.14

3.23

2.6

2.7

mosm/kgh2o

500.4

508.0

0.50

742

6650

(3045424) Erythrocytes [Presence] in Urine

106

741

1.44

3.22

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

453

5296

0.84

3.10

6.2

6.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

870

7791

1.14

3.09

3.4

3.5

ng/l

284.7

239.2

0.29

626

5692

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

553

4790

1.17

3.09

2.3

2.4

umol/l

5.5

7.1

2.59

450

4046

(3025130) Human papilloma virus identified in Specimen

119

857

1.40

3.08

1.8

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

947

8529

1.14

3.08

1.7

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

652

5725

1.16

3.06

2.2

2.3

g/l

2.4

0.13

597

5248

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

322

1.65

3.04

4.0

3.6

—

(40768795) Lymph node Pathology biopsy report

465

1.53

3.00

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

603

1.47

2.99

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

355

2967

1.21

2.97

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1117

0.68

2.94

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

306

2522

1.23

2.94

1.4

1.3

iu/l

30.4

32.4

0.44

258

2187

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

312

2578

1.22

2.93

1.1

—

(3022145) Colonoscopy Study observation

556

4844

1.17

2.89

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1476

1.29

2.89

2.3

2.2

g/l

3.0

3.1

0.56

141

1130

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1557

1.28

2.87

2.2

g/l

3.6

3.7

0.38

136

1104

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1559

1.28

2.84

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

602

1.45

2.84

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

602

5286

1.16

2.83

2.3

2.4

21.4

21.7

0.17

511

4444

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

198

1560

1.28

2.83

2.2

g/l

7.3

7.6

1.76

144

1160

(3000492) Spirometry study

446

3826

1.18

2.81

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

718

6388

1.15

2.81

1.7

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

156

1193

1.32

2.79

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

829

7457

1.13

2.75

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

3660

35565

1.11

2.73

18.1

16.2

13.7

0.16

3602

34818

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

148

1128

1.32

2.72

2.4

2.3

168.8

187.6

1.80

136

1074

(4024509)

501

1.48

2.71

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

159

1227

1.31

2.68

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

168

0.30

2.68

1.0

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1948

18378

1.10

2.67

4.1

4.3

g/l

36.1

35.7

2.74

1785

16937

(3013826) Glucose [Moles/volume] in Serum or Plasma

2530

24165

1.10

2.66

4.2

4.1

mmol/l

6.5

6.6

0.80

2353

22341

(3030981) Hyaline casts [#/volume] in Urine by Automated count

229

1852

1.25

2.65

2.2

2.5

e6/l

0.2

0.3

1.77

221

1787

(3000034) Microalbumin [Mass/volume] in Urine

343

1.58

2.64

2.1

2.9

mg/l

10.0

26.2

1.81

231

(3021601) Nitrite [Presence] in Urine by Test strip

2299

21869

1.10

2.63

5.6

5.3

estimate

0.0

0.80

392

4001

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

159

1231

1.30

2.62

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

159

1232

1.30

2.61

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

141

1075

1.32

2.60

2.1

2.2

g/l

0.0

0.00

128

988

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1456

1.27

2.57

2.0

2.2

g/l

10.2

10.0

0.25

149

1200

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

152

1174

1.30

2.56

2.2

2.1

g/l

0.0

0.78

138

1066

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

158

1230

1.29

2.51

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

701

6275

1.14

2.51

2.3

umol/l

12.5

12.9

0.59

641

5756

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

813

1.36

2.51

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1008

0.69

2.49

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

2315

22067

1.09

2.48

4.1

4.0

estimate

0.0

1.57

393

4028

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

2.06

2.46

2.9

3.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

142

1095

1.31

2.44

2.1

g/l

0.0

0.00

128

992

(3049717) Cytology report of Urine Cyto stain

128

973

1.32

2.43

2.4

2.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

144

1116

1.30

2.39

2.3

2.4

g/l

3.4

3.6

0.55

139

1057

(3009214) Lutropin [Units/volume] in Serum or Plasma

116

872

1.34

2.38

1.3

u/l

16.9

15.7

0.32

715

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1241

1.28

2.37

2.0

g/l

39.1

37.8

2.00

131

1046

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

168

1332

1.27

2.34

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

1156

1.29

2.32

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

2.32

1.2

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

135

1043

1.30

2.30

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

402

3484

1.17

2.28

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1432

13398

1.10

2.28

2.4

u/l

56.1

57.0

0.43

1293

12224

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

430

1.47

2.27

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

222

1825

1.23

2.26

8.8

7.5

mmol/l

24.5

24.4

0.12

203

1696

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

270

1.60

2.25

1.5

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

475

4176

1.15

2.23

1.9

2.1

nmol/l

373.7

379.0

0.23

424

3820

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

109

821

1.34

2.23

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

109

821

1.34

2.23

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

2270

21687

1.09

2.23

4.0

3.9

estimate

0.0

0.80

384

3985

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

203

1656

1.24

2.22

3.1

3.7

mmol/l

24.5

24.4

0.27

187

1483

(40768443) Skin Pathology biopsy report

242

2014

1.21

2.19

1.3

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.69

2.15

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.37

2.12

1.0

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

176

1427

1.24

2.06

1.2

1.3

u/ml

65.2

38.6

—

107

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

398

1.46

2.06

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.08

2.06

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

515

1.40

2.05

1.2

u/l

56.6

59.3

0.17

349

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

309

1.53

2.05

1.5

u/l

5.2

5.0

0.02

144

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

205

1693

1.22

2.03

1.8

1.9

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

534

1.39

2.01

1.2

1.3

—

33.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

151

1207

1.26

2.01

2.2

2.0

94.5

94.7

0.03

137

1108

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

224

1.61

1.99

2.4

2.5

e6/l

772.7

798.0

0.06

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

1.83

1.97

1.1

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

102

777

1.32

1.97

1.4

nmol/l

0.3

0.4

1.22

597

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1153

10747

1.10

1.97

2.3

mg/l

3.0

0.11

965

9190

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

465

4126

1.14

1.94

3.7

4.0

u/l

240.7

246.2

0.39

441

3863

(3036489) Thrombin time

183

1502

1.23

1.94

2.0

1.9

21.0

21.1

0.06

163

1277

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

160

1297

1.24

1.90

1.2

1.3

u/ml

8.9

7.2

0.12

236

(3028433) Virus identified in Specimen by Culture

143

1.75

1.88

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.88

0.0

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

349

3045

1.16

1.86

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

223

0.45

1.83

1.8

1.3

60.2

64.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

101

778

1.30

1.83

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

328

2854

1.16

1.82

1.3

au/ml

74.7

45.6

—

126

(3021387) Prolactin [Units/volume] in Serum or Plasma

180

1486

1.22

1.82

1.5

1.7

mu/l

342.7

319.2

0.30

162

1316

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

530

4767

1.13

1.80

2.3

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.05

1.80

1.1

2.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

531

1.36

1.76

1.8

2.1

mg/l

38.8

27.2

0.58

143

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

289

1.49

1.74

1.2

u/l

17.6

21.8

0.48

245

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

636

1.33

1.73

1.2

1.1

u/ml

2.0

3.2

0.82

278

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

232

1973

1.18

1.72

1.1

—

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

140

1134

1.24

1.71

2.6

2.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

282

1.49

1.71

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1233

11595

1.08

1.70

3.8

3.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

164

1352

1.22

1.70

1.4

ug/g

266.5

290.6

0.86

773

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

356

3134

1.15

1.70

2.4

au/ml

26.9

26.6

0.01

186

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

118

1.78

1.70

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

324

1.45

1.69

6.7

6.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

1262

0.78

1.68

2.8

3.6

mmol/l

1.3

0.12

1241

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

135

1096

1.24

1.63

1.2

1.3

u/ml

25.7

40.6

—

136

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

873

0.74

1.63

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

471

1.36

1.61

1.4

—

2.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

191

2259

0.84

1.61

5.4

6.7

mmol/l

25.3

24.8

0.84

186

2091

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.87

1.60

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.41

1.59

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.41

1.59

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

489

1.35

1.59

1.2

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

190

1.58

1.59

1.4

1.5

pmol/l

14.8

0.00

155

(3016038) Potassium [Moles/volume] in Urine

287

1.47

1.59

1.2

1.1

mmol/l

34.9

33.5

0.13

242

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

159

1.64

1.58

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.00

1.58

1.0

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

499

1.35

1.57

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

1.57

1.56

1.4

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4191

41305

1.10

1.55

4.5

mmol/l

5.8

2.13

3791

37656

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

372

1.40

1.55

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

157

1303

1.21

1.55

1.5

1.6

iu/ml

0.0

0.3

1.24

261

(3004588) Protein electrophoresis panel - Serum or Plasma

311

2734

1.15

1.54

2.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

265

1.48

1.53

1.0

u/ml

0.5

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1159

10920

1.08

1.52

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

275

2400

1.15

1.51

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

112

900

1.25

1.50

3.3

3.5

mg/l

22.7

23.9

0.16

540

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

172

2038

0.84

1.50

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

643

1.30

1.49

1.3

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

181

1529

1.19

1.49

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

102

812

1.26

1.49

1.3

1.4

u/l

28.6

31.2

0.33

673

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

101

1.79

1.48

1.4

1.2

—

(3020891) Body temperature

118

1448

0.81

1.48

2.9

4.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

193

1642

1.18

1.47

1.5

1.7

mg/l

2.8

3.7

0.86

124

1171

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

154

1285

1.20

1.46

1.2

1.3

u/ml

3.4

5.3

0.28

147

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.38

1.43

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

124

1015

1.23

1.42

1.2

u/ml

3.7

19.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

379

1.38

1.42

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

237

1.48

1.41

1.7

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

294

3323

0.88

1.40

2.9

2.5

ml/min/173m2

66.3

65.8

0.08

126

1316

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

205

1.52

1.40

1.2

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.42

1.39

1.3

1.2

—

2.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

899

8418

1.08

1.38

3.2

2.8

mmol/l

2.5

0.38

781

7339

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.08

1.38

1.2

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

333

3730

0.89

1.38

4.1

3.4

mmol/l

1.2

0.08

281

3223

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

182

1551

1.18

1.38

1.7

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

478

4349

1.11

1.37

1.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.61

1.36

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

715

1.26

1.36

1.3

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.97

1.32

1.1

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

249

1.45

1.32

2.3

e6/l

392.6

511.5

1.16

203

(3020630) Protein [Mass/volume] in Serum or Plasma

364

3271

1.12

1.31

2.4

2.5

g/l

66.3

66.5

0.23

321

2936

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

266

1.43

1.31

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

308

1.40

1.31

1.1

iu/ml

7.8

9.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

113

1.68

1.31

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

233

1.46

1.31

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

465

4237

1.11

1.31

2.2

2.0

—

(3000991) Gas panel - Venous blood

327

2922

1.13

1.30

7.7

6.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

1096

0.80

1.30

2.7

3.9

mmol/l

3.9

3.8

1.59

1035

(1761482) Bacteria [#/volume] in Urine by Culture

124

1027

1.21

1.30

3.8

4.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.70

1.29

3.8

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.70

1.29

3.8

3.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.78

1.28

1.0

1.1

—

(3026008) Bacteria identified in Urine by Culture

1616

15492

1.06

1.28

3.4

3.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

695

1.26

1.27

2.0

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1.35

1.27

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

211

1834

1.16

1.27

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

126

1048

1.21

1.27

1.2

1.3

u/ml

4.1

2.6

0.28

(44813793)

353

0.65

1.26

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1235

11742

1.07

1.26

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

475

4345

1.10

1.25

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

329

1.37

1.24

1.0

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

322

3583

0.89

1.22

4.2

4.0

0.8

0.9

0.15

916

(3041672) Baker's yeast Ab [Presence] in Serum

2.63

1.21

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

156

1.54

1.19

1.2

1.1

g/l

—

0.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

255

1.41

1.19

1.8

1.5

—

(4211845)

255

1.41

1.19

3.5

3.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.11

1.18

1.1

1.5

—

(3004451) EKG impression Narrative

173

1.51

1.17

1.4

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

368

3336

1.11

1.16

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

623

1.26

1.16

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

126

0.48

1.16

1.5

2.3

nmol/l

141.0

161.4

—

108

(3005322) IgE [Units/volume] in Serum or Plasma

319

2870

1.12

1.16

1.3

u/ml

154.1

180.6

0.40

294

2662

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

1.16

0.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

171

1476

1.16

1.15

1.3

miu/ml

215.8

235.4

0.35

733

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.05

1.15

5.1

6.5

—

(3016018) Differential panel - Cerebral spinal fluid

447

1.30

1.15

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

121

1015

1.20

1.14

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

369

1.33

1.14

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1075

11310

0.94

1.14

3.0

3.1

mg/l

969.3

470.9

1.25

568

6438

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

143

1219

1.18

1.13

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

440

1.30

1.12

2.1

2.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

1.62

1.12

1.1

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

619

0.76

1.11

1.3

mmol/l

6.3

7.3

1.57

454

(3013005) Retinol [Moles/volume] in Serum or Plasma

192

1.46

1.11

1.5

1.6

umol/l

2.1

2.0

0.28

182

(3045414) Leukocytes [Presence] in Urine

239

2120

1.13

1.11

2.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

209

1.44

1.10

2.2

2.6

—

31.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

185

1614

1.15

1.09

2.0

1.7

g/l

1.6

0.03

157

1367

(3022217) INR in Platelet poor plasma by Coagulation assay

531

4918

1.09

23.6

22.7

inr

1.3

0.20

715

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1199

11446

1.06

1.08

1.6

mmol/l

1.3

1.92

996

9610

(3002619) Bacteria identified in Specimen by Culture

1.69

1.07

1.1

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

310

3425

0.90

1.06

4.2

4.0

0.1

0.2

0.88

850

(3006462) Nitrate [Presence] in Urine

236

1.40

1.06

3.8

3.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

253

1.39

1.06

1.4

1.3

—

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

650

1.23

1.05

1.6

1.4

ug/l

2.8

4.1

1.48

569

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

322

1.34

1.05

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.12

1.05

1.0

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

123

0.49

1.05

1.2

1.1

—

(3036603) Volume of Urine

288

1.36

1.04

1.6

1.4

1422.2

1995.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

1.48

1.04

1.5

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

162

1.48

1.04

1.2

1.1

ng/l

568.6

382.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

1.67

1.03

5.5

4.9

mmol/l

25.5

24.9

0.46

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

866

8192

1.07

1.03

1.3

u/ml

8.3

12.7

1.56

293

3217

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

553

1.25

1.03

1.3

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

1.03

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

146

1.51

1.03

1.0

1.1

101.3

92.3

1.03

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.06

1.02

1.7

2.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.84

1.02

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.84

1.02

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.84

1.02

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

905

8577

1.07

1.02

1.3

iu/ml

30.6

34.8

0.42

280

2772

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

155

1343

1.16

1.02

1.8

iu/l

68.2

4.6

0.50

498

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

491

1.27

1.02

5.0

4.5

u/ml

49.4

94.3

0.73

140

(3007853) Bacteria identified in Skin by Aerobe culture

513

4762

1.09

1.01

1.8

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

708

1.22

1.01

1.2

1.3

—

20.3

—

(3037522) Nuclear Ab [Titer] in Serum

680

6385

1.08

1.01

1.4

titre

723.7

583.7

0.70

150

1451

(3005033) Fetal Nuchal fold Thickness US

119

1011

1.18

1.00

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

296

2678

1.11

1.00

2.5

2.9

kpa

4.5

0.10

286

2592

(1002224) Polysomnography panel

172

1506

1.15

0.99

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

592

1.24

0.99

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

440

4063

1.09

0.99

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

443

4093

1.09

0.98

2.4

1.7

1.8

1.52

379

3598

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

240

1.38

0.98

2.3

e9/l

0.2

1.24

201

(3025941) Bacteria identified in Stool by Culture

284

2568

1.11

0.98

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

157

0.57

0.98

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

452

4181

1.09

0.98

3.3

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

270

2437

1.11

0.97

2.4

2.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

154

1341

1.15

0.96

2.6

3.5

mmol/l

25.4

25.1

0.74

138

1223

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.80

0.96

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.85

0.96

4.5

8.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

122

1044

1.17

0.96

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

407

1.28

0.95

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

152

1324

1.15

0.95

2.9

3.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.65

0.94

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.89

0.94

1.0

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1099

10510

1.06

0.93

3.7

3.9

—

(4146454)

400

1.28

0.93

2.5

2.7

—

(3003181) Sodium [Moles/volume] in Urine

789

1.20

0.93

1.3

mmol/l

54.3

61.1

1.34

625

(3000093) Morphology [Interpretation] in Blood Narrative

321

1.31

0.92

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

142

1.48

0.92

1.0

1.1

103.3

96.3

0.59

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

590

1.22

0.91

1.3

nmol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

126

1.51

0.91

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

902

8584

1.06

0.91

2.4

2.5

e6/l

7.0

7.9

1.09

788

7463

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

331

1.30

0.90

2.2

u/field

1.7

2.1

0.34

137

(3035637) Corticotropin [Mass/volume] in Plasma

528

1.23

0.89

1.8

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

519

1.24

0.89

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

280

3075

0.91

0.89

2.0

2.3

ug/l

6.1

5.6

0.25

227

2594

(3025159) Blasts/100 leukocytes in Blood

296

3241

0.91

0.89

4.3

4.1

0.1

0.5

1.17

722

(3018677) aPTT in Platelet poor plasma by Coagulation assay

616

5795

1.07

0.88

1.9

29.6

29.3

0.51

602

5597

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.69

0.88

1.2

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4291

42520

1.07

0.88

4.9

4.8

mmol/l

2.8

0.00

3923

39040

(3017569) Oxygen content in Arterial blood

155

0.58

0.88

3.9

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

648

1.21

0.87

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

220

1.37

0.87

1.0

1.1

u/ml

3.5

5.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

203

1.38

0.87

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1140

11871

0.95

0.86

3.7

3.8

mg/mmol

7.5

8.3

0.21

604

6812

(3012095) Magnesium [Moles/volume] in Serum or Plasma

689

6515

1.07

0.86

2.7

2.9

mmol/l

0.8

0.04

630

6020

(3000494) Fungus identified in Specimen by Culture

524

4908

1.08

0.85

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

680

0.81

0.84

1.4

2.0

nmol/l

0.8

0.23

569

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

162

1.42

0.84

1.5

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

162

1.42

0.84

1.5

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

642

1.20

0.84

1.3

u/ml

103.0

113.5

—

152

(3035933) Granulocytes/100 leukocytes in Blood

114

0.53

0.82

1.0

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.74

0.82

1.3

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.55

0.81

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

343

3169

1.09

0.80

6.6

5.6

mmol/l

1.2

1.3

0.40

333

3066

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1308

12623

1.05

0.79

2.0

2.1

u/l

158.0

160.2

0.04

1223

11781

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

149

1317

1.14

0.79

2.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.79

0.0

1.3

—

13.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

277

1.30

0.78

1.3

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

0.00

0.78

0.0

1.7

—

61.6

—

(3004775) Volume in Urine collected for unspecified duration

258

0.70

0.78

2.2

2.3

613.2

611.2

0.01

180

(3026493) Urate [Moles/volume] in Serum or Plasma

1048

10064

1.05

0.78

2.2

2.3

umol/l

3364.0

4343.2

0.42

884

8598

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4024

39833

1.05

0.77

3.9

3.8

mmol/l

1.2

3.39

3648

36247

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

148

1.42

0.77

1.9

1.6

ug/l

0.5

0.4

0.44

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.77

0.0

2.8

—

887.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

102

880

1.16

0.77

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

367

1.26

0.77

1.3

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

140

1.43

0.76

2.4

2.6

—

(3011412) CD3 cells [#/volume] in Blood

377

1.25

0.75

2.3

2.1

e9/l

1.0

1.2

0.50

241

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

377

1.25

0.75

1.1

1.2

u/ml

52.7

64.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.70

0.75

1.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

118

1033

1.15

0.74

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

378

1.25

0.74

1.1

1.2

u/ml

45.5

42.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

223

2029

1.10

0.74

2.6

3.3

mmol/l

2.6

2.0

1.50

180

1554

(3017509) Phencyclidine [Presence] in Urine

1.84

0.73

2.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1937

18890

1.04

0.73

9.4

9.1

e9/l

0.0

0.57

1522

15398

(3050129) First trimester maternal screen panel - Serum or Plasma

169

1516

1.12

0.73

1.5

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

0.72

1.0

1.6

—

(3042631) Mycobacterium sp identified in Specimen

489

1.21

0.71

2.6

2.8

—

(40758358) Immune stain study

1.92

0.70

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.4

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

637

1.18

0.70

1.3

u/ml

59.8

58.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

340

3166

1.08

0.68

1.8

—

(3051651) Icteric interference index of Serum or Plasma

248

1.29

0.68

2.5

3.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

178

1.35

0.68

1.0

1.3

—

(3042517) Benzodiazepines panel - Urine

1.85

0.68

4.8

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.64

0.68

4.5

7.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.53

0.68

15.0

10.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

714

1.17

0.67

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

168

0.65

0.67

3.3

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

1.63

0.66

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

136

1.40

0.66

1.4

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.53

0.66

1.0

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

478

5055

0.94

0.64

1.9

1.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

166

1501

1.11

0.64

2.0

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

690

1.16

0.64

1.1

au/ml

9.9

15.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.72

0.64

4.0

1.9

umol/l

41.8

41.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.72

0.64

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

101

887

1.14

0.63

2.0

2.2

g/l

130.8

126.9

0.85

632

(3019060) Gas panel - Arterial blood

215

2341

0.91

0.63

3.5

4.8

—

(3003338) MCHC [Mass/volume]

3631

35914

1.04

0.63

18.7

17.4

g/l

330.7

330.6

0.22

3607

35657

(3003458) Phosphate [Moles/volume] in Serum or Plasma

516

4893

1.06

0.63

4.4

4.7

mmol/l

1.1

1.0

0.43

463

4485

(3028679) Herpes simplex virus Ab [Presence] in Serum

225

1.29

0.63

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

488

1.19

0.62

1.1

u/ml

0.9

0.1

0.62

(3021447) Carbon dioxide [Partial pressure] in Venous blood

347

3249

1.07

0.62

3.0

3.4

kpa

5.9

5.8

0.52

337

3160

(3009343) pH of Capillary blood

229

2109

1.09

0.62

2.6

3.3

7.4

1.74

299

(3022313) Gas panel - Capillary blood

167

1515

1.11

0.62

2.5

3.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

406

1.21

0.62

1.3

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

637

1.16

0.61

2.0

2.1

umol/l

5.0

5.9

0.39

462

(3001964) Herpes simplex virus Ag [Presence] in Specimen

130

1.39

0.61

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1120

11566

0.96

0.61

4.6

4.4

estimate

0.0

0.35

392

4009

(3047181) Lactate [Moles/volume] in Blood

106

1195

0.88

0.60

4.9

6.0

mmol/l

1.2

0.13

100

1050

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.60

1.0

—

(3045716) Anion gap in Serum or Plasma

165

1.33

0.60

2.7

2.0

mmol/l

9.0

9.4

0.16

128

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

198

0.71

0.60

10.1

16.1

nmol/l

1333.3

1571.4

0.49

191

(4198724)

122

1.39

0.60

1.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

417

1.20

0.59

1.2

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4174

41427

1.05

0.59

4.4

4.3

mmol/l

1.6

3.23

3806

38044

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

131

1.38

0.59

2.0

2.7

umol/l

24.8

27.1

0.41

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.44

0.59

1.2

1.1

umol/24h

0.8

0.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.44

0.59

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

139

1254

1.11

0.58

1.3

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4202

41716

1.05

0.58

4.4

4.3

mmol/l

4.9

0.92

3849

38512

(21494815) CD4 cells/100 lymphocytes in Specimen

300

1.24

0.58

2.0

42.7

42.4

—

(3016750) Collection duration of Urine

196

0.71

0.57

1.9

2.2

min

528.2

503.0

—

150

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.67

0.56

1.0

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.67

0.56

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.56

3.0

5.0

—

(3000330) Specific gravity of Urine by Test strip

241

2237

1.08

0.56

3.4

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

1180

12151

0.96

0.56

2.9

3.0

mmol/l

6.5

0.09

966

10137

(3023383) Lactate [Moles/volume] in Pleural fluid

0.57

0.56

1.0

1.2

mmol/l

3.8

3.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

592

0.84

0.56

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

363

0.80

0.55

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.62

0.55

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

860

1.13

0.55

1.3

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

230

2133

1.08

0.55

2.7

3.4

kpa

5.2

0.28

217

1975

(3028026) IgM [Mass/volume] in Serum or Plasma

260

2423

1.08

0.55

2.1

1.8

g/l

1.3

0.22

236

2201

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

251

0.76

0.55

1.0

ng/l

859.6

730.5

0.45

172

(3019309) Folate [Moles/volume] in Red Blood Cells

820

7906

1.04

0.54

1.8

1.7

nmol/l

1122.3

1195.0

1.34

585

5944

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

186

1.29

0.54

2.2

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

1.28

0.54

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

1.28

0.54

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

367

1.20

0.54

1.2

1.4

mmol/l

10.7

12.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

718

0.86

0.54

2.4

2.7

kpa

8.1

8.2

0.35

668

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

387

3662

1.06

0.53

1.3

1.2

iu/ml

168.1

156.5

0.18

135

1423

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

193

0.72

0.53

9.6

10.9

nmol/l

734.7

851.3

0.47

185

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

215

0.74

0.52

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.46

0.50

2.2

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

125

1134

1.10

0.50

1.3

1.2

titre

150.0

193.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

270

1.22

0.49

1.1

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

261

1.23

0.49

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

473

1.16

0.49

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

235

0.77

0.49

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

341

3225

1.06

0.49

3.1

3.4

mmol/l

2.0

2.1

0.01

298

2677

(3038177) Helicobacter pylori Ab [Presence] in Serum

765

1.13

0.48

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

474

1.16

0.48

2.5

3.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

262

1.22

0.48

1.0

u/ml

0.4

2.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

111

0.63

0.48

2.1

2.3

—

139.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

419

1.17

0.47

1.2

—

(3019150) Specific gravity of Urine by Refractometry

913

9408

0.96

0.46

4.5

kg/l

1.0

1.35

131

1483

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

1.24

0.46

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

216

2311

0.93

0.46

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.43

0.45

1.7

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.59

0.45

1.0

1.2

—

3.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

722

1.12

0.45

1.1

1.2

—

(3008898) HLA-B27 [Presence]

172

1594

1.08

0.45

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.40

0.45

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

201

1.25

0.44

1.1

—

(3019977) pH of Arterial blood

192

1.25

0.44

4.0

2.9

7.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

422

1.16

0.44

5.0

6.4

mg/l

12.6

12.1

0.36

389

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

351

0.83

0.44

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

461

1.15

0.43

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.61

0.43

2.2

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

821

1.11

0.42

2.8

3.3

nmol/l

0.7

0.8

2.04

637

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

322

1.18

0.42

1.3

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

360

0.83

0.42

1.5

1.6

mmol/l

7.3

7.7

0.24

218

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

267

1.20

0.42

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.43

0.41

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

313

3294

0.95

0.41

4.0

3.8

0.7

0.6

0.18

666

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.41

0.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

314

1.18

0.41

1.3

mmol/l

2.0

2.1

0.39

296

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

451.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

259

2448

1.06

0.40

1.3

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

625

0.88

0.40

2.1

2.6

umol/l

35.3

32.3

0.30

532

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

186

1.24

0.40

2.8

2.3

—

(3009871) Measles virus Ab [Titer] in Serum

132

1.29

0.40

1.6

1.8

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.40

0.0

1.0

—

94.2

—

(3011648) Oxygen content in Venous blood

278

1.19

0.39

1.7

2.0

9.3

10.8

1.38

278

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

314

0.83

0.39

1.4

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

160

0.75

0.39

2.4

3.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.31

0.39

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.31

0.39

1.1

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

550

1.13

0.39

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.43

0.39

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

313

3286

0.95

0.39

2.3

2.8

ng/l

207.3

170.3

0.77

276

2993

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

1.18

0.38

1.1

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

169

1.24

0.38

5.2

11.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

627

1.12

0.38

1.3

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

618

1.12

0.38

1.1

123.1

122.4

0.06

549

(3019832) Treponema pallidum Ab [Presence] in Serum

433

4159

1.05

0.38

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

590

1.12

0.37

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

590

1.12

0.37

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

239

2262

1.06

0.37

1.4

1.5

—

(3033799) Differential panel - Peritoneal fluid

114

0.70

0.37

1.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

641

0.89

0.37

1.1

1.5

—

(3044889) 12 lead EKG panel

2958

29292

1.02

0.36

3.7

3.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

281

1.18

0.36

1.2

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

412

1.14

0.36

2.7

3.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

933

0.91

0.36

1.4

e6/l

1992.5

1287.1

0.19

759

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

592

1.12

0.36

1.3

1.4

—

(40757373) Influenza virus identified in Isolate

1.27

0.36

1.2

1.5

—

(4027681)

256

0.82

0.36

1.4

1.2

—

(4133840)

0.65

0.35

1.8

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

593

1.11

0.35

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

861

1.09

0.35

1.2

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

931

0.91

0.35

1.3

e6/l

15.2

24.6

0.60

711

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

329

1.16

0.35

1.2

1.3

u/ml

0.1

1.4

2.06

135

(3011288) Drugs identified in Urine by Screen method

878

0.91

0.34

1.7

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

729

1.10

0.33

1.5

1.6

—

(21494755) Public health laboratory ask at order entry panel

343

3575

0.96

0.33

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

596

1.11

0.33

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

312

1.15

0.33

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

324

3105

1.05

0.33

2.7

2.8

g/l

10.2

10.3

0.33

294

2839

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

606

1.11

0.33

1.4

—

(3037121) Protein [Mass/volume] in Urine

143

1339

1.07

0.32

2.5

2.7

g/l

0.4

0.3

0.15

432

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

150

1407

1.07

0.32

2.3

1.8

g/l

0.2

0.42

139

1325

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.35

0.32

1.2

2.0

umol/l

13.7

17.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.35

0.32

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

0.76

0.32

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

116

1079

1.08

0.31

1.8

1.6

—

(4015189)

101

1.29

0.31

2.1

2.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

685

1.10

0.31

3.1

4.4

iu/ml

143.1

328.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

244

2327

1.05

0.31

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

903

0.92

0.31

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.32

0.30

1.6

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

100

0.70

0.30

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

368

0.87

0.30

2.3

2.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

184

1.20

0.30

1.7

2.4

umol/l

87.4

159.7

1.68

109

(3012441) Differential panel - Pleural fluid

296

1.15

0.30

1.2

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

787

0.91

0.30

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

293

0.85

0.30

1.1

ratio

1.1

—

105

(3000475) Leukocytes [#/volume] in Synovial fluid

107

996

1.08

0.29

1.6

e6/l

14893.3

10918.3

0.37

711

(3023520) Reticulocytes [#/volume] in Blood

317

3049

1.04

0.29

2.4

e9/l

70.7

71.1

0.06

234

2256

(3035320) C reactive protein [Mass/volume] in Body fluid

335

1.14

0.29

2.3

2.2

—

(3045142) Bone marrow Pathology biopsy report

421

1.12

0.28

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

651

1.09

0.28

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

308

1.14

0.27

1.3

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

153

1447

1.06

0.27

2.3

1.8

g/l

1.2

0.03

142

1365

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

918

9365

0.98

0.27

1.7

1.6

pmol/l

81191273.5

30158772.5

1.04

739

7706

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

116

0.78

0.27

1.1

—

(4268621)

432

1.11

0.27

2.8

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

394

1.12

0.27

1.2

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

168

1.19

0.27

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

259

2486

1.04

0.27

1.6

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

437

0.89

0.26

2.8

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.28

0.26

1.5

1.3

ng/l

85.9

93.4

0.21

(3005011) Chlamydia sp Ab [Titer] in Serum

0.70

0.26

2.4

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.30

0.26

1.0

1.1

ug/l

99.5

74.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

139

1314

1.06

0.26

1.1

u/ml

2.4

7.1

1.45

140

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.68

0.26

1.0

1.2

pmol/l

12.0

14.4

—

(4281824)

703

1.08

0.25

1.1

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

945

9627

0.98

0.25

4.1

4.3

—

(1761868) Lipid panel - Serum or Plasma

1431

14510

0.98

0.25

2.8

—

(3022621) pH of Urine by Test strip

316

3052

1.04

0.25

3.4

3.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

372

0.89

0.25

1.3

1.4

e6/l

211441.2

90682.8

0.33

241

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

212

2213

0.96

0.25

9.2

7.4

0.6

0.7

0.92

212

2202

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.18

0.24

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

756

0.92

0.24

2.4

ug/min

19.2

72.8

3.09

437

(3027135) IgG subclass 1 [Mass/volume] in Serum

444

0.90

0.24

1.3

1.4

g/l

6.5

6.7

0.14

310

(3041354) Potassium [Moles/volume] in Venous blood

444

0.90

0.24

2.8

2.1

mmol/l

4.0

0.04

439

(3035285) Chloride [Moles/volume] in Venous blood

444

0.90

0.24

2.8

2.1

mmol/l

106.3

105.4

0.74

439

(3024139) IgG subclass 3 [Mass/volume] in Serum

444

0.90

0.24

1.3

1.4

g/l

0.3

0.4

1.55

313

(3028192) IgG subclass 2 [Mass/volume] in Serum

444

0.90

0.24

1.3

1.4

g/l

2.5

2.8

0.46

311

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

274

1.13

0.24

1.1

nmol/l

12.1

12.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3876

38587

1.02

0.23

5.4

5.5

mmol/mol

38.7

39.1

2.43

3568

35602

(3017446) Testosterone [Moles/volume] in Serum or Plasma

360

1.11

0.23

1.2

1.3

nmol/l

1.0

1.5

1.88

289

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

254

0.87

0.23

1.1

u/l

1.0

1.1

—

115

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

1037

1.06

0.23

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

243

0.86

0.23

1.5

1.6

promille

1.3

1.1

0.35

181

(3012501) Base excess in Blood by calculation

853

1.07

0.23

3.1

3.4

mmol/l

2.8

2.7

0.07

601

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

264

0.87

0.23

1.7

1.6

u/l

4.2

5.2

1.53

223

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

567

0.92

0.22

1.2

1.1

iu/ml

45.8

18031.3

0.55

132

(3001019) Free T4 and TSH panel - Serum or Plasma

247

2561

0.96

0.22

1.9

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.25

0.22

1.2

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

874

1.07

0.22

4.4

3.6

58.7

57.2

0.60

874

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

1.1

—

(3003396) Base excess in Arterial blood by calculation

421

4100

1.03

0.22

6.8

6.3

mmol/l

1.3

1.2

0.15

353

3242

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

681

1.07

0.21

1.1

1.2

u/ml

300.6

268.8

0.32

430

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.5

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.4

—

28.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

3.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

12097.4

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.21

0.0

1.1

—

24.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

460

4491

1.03

0.20

6.2

5.9

mmol/l

104.3

0.09

449

4402

(3047189) Immunofixation for 24 hour Urine

164

1.16

0.20

1.2

1.6

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

47.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.25

0.20

2.0

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

596

1.07

0.20

1.1

u/ml

2.4

3.6

0.42

216

(3011436) Histone Ab [Units/volume] in Serum

112

0.80

0.20

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

645

0.93

0.20

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

0.80

0.20

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

115

0.78

0.20

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.20

0.19

1.2

1.4

—

(3010421) pH of Blood

106

1006

1.05

0.19

2.9

3.3

7.4

0.58

840

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.18

0.19

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

899

1.06

0.19

3.0

mg/l

1.4

1.5

0.38

827

(3040151) Glucose [Moles/volume] in Capillary blood

404

1.09

0.19

4.2

mmol/l

8.5

7.1

0.98

332

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.22

0.19

1.0

1.1

u/ml

26.3

52.1

1.60

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

385

1.09

0.19

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

569

1.07

0.19

1.7

2.1

—

(3021788) Differential panel - Synovial fluid

754

1.06

0.18

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

389

3797

1.03

0.18

4.9

4.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

332

0.90

0.18

1.5

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

473

1.08

0.18

1.2

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

551

1.07

0.18

1.1

u/ml

4.6

3.4

0.15

206

(3014051) Protein [Presence] in Urine by Test strip

119

1137

1.05

0.18

2.3

2.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

233

1.12

0.17

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

138

1324

1.04

0.17

1.7

titre

88.0

324.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

174

1678

1.04

0.17

1.6

u/ml

5.8

15.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

620

1.07

0.17

3.6

3.1

1.0

1.4

0.98

482

(3010726) Horse dander IgE Ab [Units/volume] in Serum

679

1.06

0.17

1.1

u/ml

2.4

1.4

0.19

154

(4062490)

444

0.92

0.17

1.3

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.75

0.17

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

120

0.83

0.16

1.1

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

215

1.12

0.16

1.2

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

720

1.06

0.16

1.1

u/ml

0.8

0.9

0.14

289

(21494434) Karyotype in Bone marrow

283

1.10

0.15

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

130

1.15

0.15

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

130

1.15

0.15

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

596

0.94

0.15

2.4

2.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.76

0.15

1.8

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

913

0.95

0.15

3.3

—

(3048879) Bone marrow aspiration report

102

1.18

0.15

2.0

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

513

0.94

0.15

1.1

1.2

u/l

26.7

28.2

0.06

446

(3044941) Cell count panel - Synovial fluid

646

0.94

0.15

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

244

0.90

0.14

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

111

1066

1.04

0.14

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.80

0.14

1.3

1.2

—

(4010399)

307

3138

0.98

0.14

1.4

—

(4306422)

636

1.05

0.14

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

305

0.92

0.13

1.5

1.2

titre

80.0

194.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.81

0.13

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.81

0.13

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.81

0.13

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.81

0.13

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

0.80

0.13

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

539

1.06

0.13

1.2

—

(40765096) Chromosome analysis panel by Banding

1.17

0.13

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

109

0.83

0.13

1.3

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

0.82

0.13

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

846

0.96

0.13

1.2

1.1

u/ml

0.7

1.0

0.35

311

(3023487) Leukocytes [#/volume] in Peritoneal fluid

127

0.87

0.12

1.9

2.1

e6/l

1569.8

756.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

174

1788

0.97

0.12

1.7

2.0

u/l

41.9

40.2

0.51

152

1598

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

400

4068

0.98

0.12

1.7

1.6

1.4

0.20

354

3574

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

210

0.90

0.12

1.1

1.0

90.5

93.1

0.17

159

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

133

1.13

0.12

2.1

1.6

ug/l

8.8

8.7

0.06

133

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

191

1.10

0.11

1.1

—

(44790048)

405

1.06

0.11

1.3

1.4

—

(44806118)

405

1.06

0.11

1.3

1.4

—

(44790047)

405

1.06

0.11

1.3

1.4

—

(44790049)

405

1.06

0.11

1.3

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

143

1.12

0.11

1.1

4.6

mg/l

94.1

59.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

126

1222

1.03

0.11

3.0

3.2

mg/l

25.2

39.3

1.66

991

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

1.05

0.11

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

126

1223

1.03

0.11

3.0

3.2

mg/l

35.8

94.1

0.68

995

(3036071) Salmonella sp Ab [Titer] in Serum

134

1.12

0.10

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

270

0.93

0.10

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

170

1659

1.03

0.10

2.3

2.6

1.2

0.04

170

1645

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

115

1.13

0.10

2.2

2.0

mg/l

9.3

10.1

0.16

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

1.09

0.10

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

202

1.09

0.10

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

177

0.90

0.10

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

177

0.90

0.10

1.3

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.14

0.10

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.11

0.09

1.2

umol/24h

1.7

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

126

1226

1.03

0.09

1.9

2.1

ug/l

425.7

614.6

0.39

117

1128

(3047007) Chlamydophila sp Ab [Presence] in Serum

634

1.04

0.09

1.2

—

(3016502) Oxygen saturation in Arterial blood

354

3592

0.98

0.09

7.2

6.6

95.9

95.8

0.00

348

3451

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.06

0.09

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

635

1.04

0.09

1.4

1.2

u/ml

2.3

4.2

2.18

254

(40767503) Oxygen content in Capillary blood by calculation

793

1.03

0.09

2.0

2.5

16.2

16.1

0.06

388

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.11

0.09

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

754

1.04

0.09

1.1

u/ml

6.2

4.4

0.31

365

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.09

0.08

1.0

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

416

4109

1.01

0.08

6.8

6.2

kpa

12.8

12.7

0.17

402

3899

(3024263) Appearance of Synovial fluid

204

1.08

0.08

1.2

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.05

0.08

1.3

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

400

1.05

0.08

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

998

0.97

0.08

1.6

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

927

0.97

0.08

1.2

mmol/l

3.7

0.19

877

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

144

0.90

0.08

1.2

1.7

25.3

28.2

0.46

134

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

416

4112

1.01

0.08

6.8

6.2

kpa

5.2

5.1

0.91

398

3909

(3024869) Neuronal Ab [Presence] in Serum

1.09

0.08

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.14

0.08

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

123

0.89

0.08

3.5

3.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

246

0.93

0.08

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

855

1.03

0.08

1.6

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

121

1182

1.02

0.07

2.8

3.1

ratio

3.1

1.5

—

107

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

166

1.08

0.07

1.2

2.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.83

0.07

3.5

2.6

u/l

50.5

2220.3

—

(3042733) HLA Ab [Presence] in Serum

0.82

0.07

4.3

5.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

648

1.03

0.07

1.4

1.2

u/ml

9.2

3.7

0.51

193

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

0.81

0.07

1.0

1.5

30.7

21.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1648

16553

0.99

0.07

4.4

4.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.03

0.07

1.3

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.07

0.07

1.0

1.1

—

71.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.06

0.07

1.0

1.1

—

288.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

137

1343

1.02

0.07

1.7

1.9

ug/l

2.2

1.8

0.22

113

1173

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

120

1175

1.02

0.06

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

407

0.96

0.06

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.84

0.06

1.3

1.4

umol/l

17.0

17.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

366

0.96

0.06

1.2

1.4

e6/l

5167.3

2189.2

0.42

271

(3015183) Erythrocyte sedimentation rate

207

1.06

0.06

1.1

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

638

0.97

0.06

1.1

—

(3045788) Cell count panel - Pleural fluid

294

0.95

0.06

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

182

0.93

0.05

1.9

2.3

46.8

43.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

129

1.09

0.05

1.1

u/ml

0.1

2.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

131

0.92

0.05

1.2

2.1

ug/l

1.3

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

141

0.92

0.05

1.6

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

139

1.08

0.05

2.3

1.8

—

(3000012) Reticulocyte production index

218

1.06

0.05

1.4

—

(3035880) pH of Pleural fluid

161

0.93

0.05

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

303

0.96

0.05

1.8

2.0

mmol/l

6.3

6.4

0.10

210

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

307

1.04

0.05

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

110

1.09

0.05

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

323

0.96

0.05

1.2

1.4

e6/l

5605.9

66326.7

1.75

183

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

1.06

0.04

1.4

—

(3027008) Opiates [Presence] in Urine

127

1289

0.98

0.04

1.5

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

814

1.02

0.04

4.2

3.0

u/ml

366.9

737.6

0.43

734

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

534

0.97

0.04

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

170

1.06

0.04

2.2

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

378

1.03

0.04

2.9

3.0

50.9

56.9

0.76

246

(3014271) Vancomycin [Susceptibility]

210

1.05

0.03

3.4

3.0

—

(3011985) Renin [Units/volume] in Plasma

597

1.02

0.03

1.7

1.5

mu/l

51.5

52.7

0.02

534

(3044927) Protein electrophoresis panel - Urine

399

1.03

0.03

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

127

1285

0.99

0.03

1.5

1.7

—

(3016879) Cocaine [Presence] in Urine

116

1174

0.99

0.03

1.5

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

559

1.02

0.03

1.3

pmol/l

274.9

355.1

0.68

432

(3028300) Cannabinoids [Presence] in Urine

128

1293

0.99

0.02

1.5

1.7

—

(3008295) Osmolality of Serum or Plasma

460

0.98

0.02

1.5

1.4

mosm/kgh2o

279.4

276.0

0.47

354

(3034426) Prothrombin time (PT)

142

1.06

0.02

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

510

1.02

0.02

1.6

51.6

55.2

0.27

305

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

321

1.03

0.02

1.4

1.6

u/ml

20.0

20.5

—

(40768806) Pleura Pathology biopsy report

321

1.03

0.02

1.2

1.6

—

(3017704) Immunofixation for Urine

188

0.96

0.02

1.0

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

191

1897

1.01

0.02

10.2

8.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

110

1111

0.99

0.02

3.4

3.1

u/ml

0.4

0.19

643

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

133

1.05

0.01

2.6

3.1

ng/l

33.0

137.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

153

1.05

0.01

1.4

2.7

—

(3006653) Thiamine [Moles/volume] in Blood

187

0.96

0.01

1.3

1.4

nmol/l

129.7

128.4

0.05

187

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

243

1.03

0.01

1.5

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

748

0.99

0.01

1.2

1.3

—

84.3

—

(3027944) Amphetamines [Presence] in Urine

126

1268

0.99

0.01

1.6

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

827

0.99

0.01

2.7

2.9

mmol/l

26.8

25.2

1.76

730

(3020650) Glucose [Presence] in Urine

106

0.94

0.01

1.7

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

114

1.05

0.00

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

191

1917

1.00

0.00

2.3

2.1

u/l

6206.0

5371.4

0.14

774

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

148

1.01

0.00

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

182

0.99

0.00

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.05

0.00

1.9

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

278

1.01

0.00

2.7

3.5

mu/l

21.1

26.7

0.41

266

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

308

1.01

0.00

1.8

9.8

14.0

1.86

130

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

155

1.03

0.00

3.6

4.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

678

1.00

0.00

1.5

g/l

1.0

0.6

0.68

507

(3037756) Immunofixation for Serum or Plasma

788

1.00

0.00

1.5

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

355

1.01

0.00

1.3

1.6

34.4

36.0

0.09

200

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.04

0.00

1.7

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

164

0.98

0.00

1.2

—

(40768441) Liver Pathology biopsy report

326

1.01

0.00

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

197

1.02

0.00

1.1

miu/ml

1884.1

1523.4

0.56

197

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

514

0.99

0.00

1.6

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

297

1.01

0.00

1.7

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

357

1.01

0.00

1.3

1.8

—

(1616796) Gas panel - Central venous blood

797

1.00

0.00

3.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

149

1.01

0.00

28.7

23.8

ug/l

97.0

100.7

0.09

121

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

189

1.01

0.00

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

146

1463

1.00

0.00

3.4

3.1

u/ml

382.3

1134.8

0.81

121

1240

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1.00

0.00

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

321

1.00

0.00

1.2

1.1

mg/l

250.9

225.9

0.28

281

(3015171) Extractable nuclear Ab [Units/volume] in Serum

202

2019

1.00

0.00

1.3

u/ml

1.3

1.1

0.07

196

(3020779) Urea [Moles/volume] in Serum or Plasma

292

2921

1.00

0.00

5.4

6.3

mmol/l

9.0

0.04

277

2786

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

87.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.7

—

336.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.1

—

0.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

6.1

—

1.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

5.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.90

0.00

1.8

6.6

—

(3044007) Cell count panel - Peritoneal fluid

110

1.00

0.00

1.6

2.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.98

0.00

1.0

—

102.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

114

1140

1.00

0.00

1.7

2.1

mg/l

11.0

11.3

0.10

102

1057

(3024932) HLA-DR beta [Type]

0.95

0.00

1.4

1.2

—

(44806071)

0.94

0.00

1.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.93

0.00

1.4

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.98

0.00

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1205.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.93

0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.1

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

3.0

—

0.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.91

0.00

1.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

130

1.00

0.00

1.0

1.2

g/l

41.0

37.9

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.93

0.00

1.6

1.3

pmol/l

15.4

19.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BREAST and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BREAST	1.045 [0.95, 1.15]	0.36
Birth year	0.999 [0.99, 1.01]	0.807

During the follow-up period (1.1.1998 — 31.12.2019), 1574 out of 17928 females with CD2_BENIGN_BREAST died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BREAST.

N-year risk	Females	Males
1	0.102%	No data
5	0.61%	No data
10	1.804%	No data
15	3.457%	No data
20	6.259%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BREAST – Benign neoplasm of breast

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm of breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints